sb 203580 has been researched along with Dysmyelopoietic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buitenhuis, M; Coffer, PJ; Geest, CR; Vellenga, E | 1 |
| Arantes, C; Brentani, MM; da Costa, SV; Junqueira, MS; Roela, RA | 1 |
2 other study(ies) available for sb 203580 and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia.
Topics: Adult; Aged; Antigens, CD34; Apoptosis; Blotting, Western; Bone Marrow Cells; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Proliferation; Cells, Cultured; Gene Expression; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Imidazoles; Immunohistochemistry; Inhibitor of Differentiation Protein 1; Middle Aged; Myelodysplastic Syndromes; Neutrophils; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; STAT5 Transcription Factor; Time Factors; Transfection; Tumor Suppressor Proteins | 2009 |
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes.
Topics: Anthracenes; Bone Marrow Cells; Cells, Cultured; Child; Child, Preschool; Female; Flavonoids; Humans; Imidazoles; Infant; Leukemia Inhibitory Factor; Male; Myelodysplastic Syndromes; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Serum; Stromal Cells | 2010 |